CUSIP 03940C100COMMON STOCKACLXGBXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
218 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 6.72M | $438.20M | 0 | Held |
| 2 | Paradigm Biocapital Advisors LP | 5.72M | $373.21M | +1.07M | Added |
| 3 | Vanguard Group Inc | 4.08M | $266.12M | +174.4K | Added |
| 4 | Fmr LLC | 3.56M | $232.36M |
| −2.20M |
| Reduced |
| 5 | Blackrock, Inc. | 3.55M | $231.38M | +160.9K | Added |
| 6 | Nea Management Company, LLC | 3.05M | $198.55M | 0 | Held |
| 7 | Vestal Point Capital, LP | 2.92M | $190.71M | +1.68M | Added |
| 8 | Sr One Capital Management, LP | 2.35M | $153.00M | 0 | Held |
| 9 | State Street Corp | 2.00M | $130.30M | +472.5K | Added |
| 10 | Citadel Advisors LLC | 1.50M | $97.81M | +478.8K | Added |
See every fund holding Arcellx Inc, with full quarter-over-quarter share changes.
Unlock all holders